Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 6.27B 928M 803M 750M 688M 1.29B 88.36B 1.31B 8.8B 3.45B 44.29B 3.49B 3.41B 146B P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 7.14B 1.06B 915M 855M 784M 1.47B 101B 1.5B 10.03B 3.94B 50.47B 3.97B 3.89B 167B EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
67.53%
Yield 2024 *
-
Yield 2025 -
1 day+1.32%
1 week-0.22%
Current month-0.22%
1 month+2.46%
3 months-7.65%
6 months+8.00%
Current year+5.52%
1 week 4.51
Extreme 4.51
4.64
1 month 4.36
Extreme 4.36
4.83
Current year 4.08
Extreme 4.08
5.47
1 year 4.08
Extreme 4.08
6.54
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
25.83
Manager TitleAgeSince
Chief Executive Officer 56 2015-04-01
Director of Finance/CFO 41 2020-12-28
Corporate Officer/Principal 42 2014-01-26
Director TitleAgeSince
Chairman 56 2026-03-26
Director/Board Member 58 2007-12-24
Director/Board Member 42 2014-01-26
Date Insider Type Main position Quantity % Market Cap.
9/21/20 Sell

Chairman

1,940,600 0.2495%
9/18/20 Sell

Director

3,670,000 0.4719%
9/18/20 Sell

Chairman

296,500 0.0381%
Change 5-day change 1-year change 3-year change Capi.($)
+1.32%-0.22%-25.12%-43.61% 928M
+0.14%-3.97%-9.18%-6.40% 13.42B
+0.85%-4.86%-31.19%-56.13% 5.09B
-0.84%-2.23%+4.50%-1.89% 5.05B
+4.49%+0.59%+6.32%-29.15% 4.21B
+0.84%-2.90%-6.91%-8.87% 3.69B
-4.39%-3.50%-2.12%+4.52% 3.54B
+1.48%-2.48%-2.48%+17.75% 3.48B
+3.37%+1.21%-11.98%-18.33% 2.49B
+0.23%-3.30%-3.72%+46.80% 1.86B
Average +0.75%-1.92%-8.19%-9.53% 4.37B
Weighted average by Cap. +0.54%-2.32%-7.64%-10.47%

Financials

2024 2025
Net sales 3.83B 567M 490M 458M 420M 790M 53.95B 803M 5.37B 2.11B 27.04B 2.13B 2.08B 89.39B 3.05B 452M 391M 365M 335M 630M 42.99B 640M 4.28B 1.68B 21.55B 1.7B 1.66B 71.24B
Net income 33.62M 4.98M 4.31M 4.02M 3.69M 6.94M 474M 7.05M 47.22M 18.53M 238M 18.71M 18.3M 786M -104M -15.46M -13.38M -12.49M -11.46M -21.55M -1.47B -21.9M -147M -57.53M -738M -58.07M -56.8M -2.44B
Net Debt 1.4B 207M 179M 168M 154M 289M 19.75B 294M 1.97B 772M 9.9B 779M 762M 32.72B 875M 130M 112M 105M 96.04M 181M 12.33B 184M 1.23B 482M 6.18B 487M 476M 20.44B
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
26-08-07 CN¥4.590 +1.32% 10,291,100
26-08-06 CN¥4.530 -1.52% 7,663,400
26-08-05 CN¥4.600 +0.66% 6,274,200
26-08-04 CN¥4.570 -0.44% 5,390,400
26-08-03 CN¥4.590 -0.22% 5,984,900

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002424 Stock